Frontiers in immunology · 2026
Transcriptomic rewiring of the JAK-STAT pathway in circulating CD4+CLA+ and CD4+ naïve T cells from patients with atopic dermatitis and psoriasis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pook Martin, Maruste Regina, Kolberg Peep, Alasoo Kaur, Org Tõnis, Raam Liisi, Remm Anu, Greco Dario, Federico Antonio, Kingo Külli, Kisand Kai, Rebane Ana
Аннотация
BACKGROUND: Skin-homing cutaneous lymphocyte-associated antigen (CLA)-expressing T cells play a key role in the pathogenesis of atopic dermatitis (AD) and psoriasis (Ps). We aimed to characterize the transcriptomic and epigenetic profiles of circulating CD4+CLA+ and CD4+ naïve T cells from patients with AD and Ps to find shared and unique molecular signatures associated with the diseases.
METHODS: Circulating CD4+CLA+ and CD4+ naïve T cells were sorted from the peripheral blood mononuclear cells of patients with AD (n = 11), those with Ps (n = 10), and healthy individuals (n = 11), followed by assay for transposase-accessible chromatin sequencing (ATAC-seq) and mRNA sequencing and data analyses.
RESULTS: Transcriptomic and epigenetic landscapes differed markedly between CD4+CLA+ and CD4+ naïve T cells. In both AD and Ps, transcriptomic alterations within these cell populations were substantial, whereas changes in chromatin accessibility were relatively modest. In CLA+ T cells, patients with AD and Ps exhibited altered expression of genes involved in T-cell activation, cell cycle, and JAK-STAT signaling. These effects were more pronounced in AD, while a stronger association with innate immune activation was seen in Ps. Notably, CD4+ naïve T cells also exhibited disease-associated transcriptomic changes in both AD and Ps, including alterations in the JAK-STAT pathway and changes in the expression of IL-2 receptor components. Epigenetic profiling further revealed disease-associated chromatin regions linked to transcription factors involved in immune regulation.
CONCLUSION: Both CD4+CLA+ and CD4+ naïve T cells exhibit transcriptomic and epigenetic alterations in AD and Ps, suggesting the influence of the chronic inflammatory milieu leading to shared and disease-specific changes, including transcriptomic rewiring of the JAK-STAT pathway in both diseases.
METHODS: Circulating CD4+CLA+ and CD4+ naïve T cells were sorted from the peripheral blood mononuclear cells of patients with AD (n = 11), those with Ps (n = 10), and healthy individuals (n = 11), followed by assay for transposase-accessible chromatin sequencing (ATAC-seq) and mRNA sequencing and data analyses.
RESULTS: Transcriptomic and epigenetic landscapes differed markedly between CD4+CLA+ and CD4+ naïve T cells. In both AD and Ps, transcriptomic alterations within these cell populations were substantial, whereas changes in chromatin accessibility were relatively modest. In CLA+ T cells, patients with AD and Ps exhibited altered expression of genes involved in T-cell activation, cell cycle, and JAK-STAT signaling. These effects were more pronounced in AD, while a stronger association with innate immune activation was seen in Ps. Notably, CD4+ naïve T cells also exhibited disease-associated transcriptomic changes in both AD and Ps, including alterations in the JAK-STAT pathway and changes in the expression of IL-2 receptor components. Epigenetic profiling further revealed disease-associated chromatin regions linked to transcription factors involved in immune regulation.
CONCLUSION: Both CD4+CLA+ and CD4+ naïve T cells exhibit transcriptomic and epigenetic alterations in AD and Ps, suggesting the influence of the chronic inflammatory milieu leading to shared and disease-specific changes, including transcriptomic rewiring of the JAK-STAT pathway in both diseases.